Navigation Links
Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
Date:5/7/2008

84 384

Total operating expenses 59,140 41,062

Interest and other income, net 2,066 4,256

Net loss (54,465) (31,895)

Dividends on redeemable convertible

preferred stock (540) (514)

Net loss allocable to common

stockholders $(55,005) $(32,409)

Net loss per share allocable to common

stockholders, basic and diluted $(0.75) $(0.53)

Shares used in calculating net loss per

share allocable to common stockholders,

basic and diluted 73,605 60,734

Arena Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheet Data

(In thousands)

March 31, 2008 December 31, 2007

(unaudited) (Note)

Assets

Cash, cash equivalents and

short-term investments $333,636 $398,185

Accounts receivable 2,398 1,901

Other current assets 8,938 9,162

Land, property and equipment, net 92,704 65,940

Acquired technology and other

non-current assets 26,857 12,318

Total assets $464,533 $487,506

Liabilities and Stockholders' Equity

Accounts payable, accrued expenses

and accrued compensation $38,345 $30,058

Total deferred revenues 4,049 4,049

Total lease financing obligations

and other long-term liabilities 72,067 63,100

Redeemable convertible pref
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Nine field days to promote ... Indiana. Hosted by the Soil Health Partnership , the field days will demonstrate ... while potentially increasing farm productivity and income. , Brent Bible has practiced no-till farming ...
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences ... company focused on the development of autologous cell therapies, announced ... presenting at the InvestMNT conference held in Minneapolis, ... AM local time. Hall,s presentation will highlight RepliCel,s 18-month milestones ... in Europe , clinical data from both ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report ... the current state of the global Propanol market with a focus on the Chinese ... Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and ...
Breaking Biology Technology:Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3
... Jan. 8 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ... Executive Officer and Dr. William P. Sheridan, Chief Medical Officer ... Morgan 27th Annual Healthcare Conference on Thursday, January 15, 2009 ... held January 12-15, 2009 in San Francisco.A link to a ...
... MOUNTAIN VIEW, Calif., Jan. 8 Concentric Medical, Inc., ... ischemic stroke patients, today announced that it has completed ... was led by leading venture capital firm New Enterprise ... new investors."The positive developments at Concentric over the last ...
... International Conference on Health Informatics (HEALTHINF 2009) will feature OpenClinica in ... Time is Ripe" , ... Porto, Portugal (PRWEB) January ... of the upcoming International Conference on Health Informatics (HEALTHINF 2009) January ...
Cached Biology Technology:BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference 2BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference 3Concentric Medical Closes on $15 Million Financing 2OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal 2
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... de julio de 2015 BGI llevará a cabo ... del 22 al 25 de octubre de 2015, en ... conferencia celebra su décimo aniversario este año. Desde su ... de las reuniones anuales más influyentes del mundo en ... las conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... to grow, so does the demand for monitoring and labeling ... tweaked to make them more healthful or pest-resistant, but some ... and enforce regulations, scientists are reporting in ACS, journal ... modifications in one convenient, accurate test. Li-Tao Yang, ...
... work hard and spend enormous resources on the conservation ... optimally spent. One big problem is international legislation and ... or global networks. Zoo resources can be spent much ... after analyzing animal collections across the world,s zoos. ...
... of Jyvskyl in Finland have developed a novel method to ... to obtain new information on trafficking of viruses in cells ... opening inside cells. This new information is important for example ... published in the journal Proceedings of the National Academy ...
Cached Biology News:Scientists warn: Conservation work in zoos is too random 2Scientists warn: Conservation work in zoos is too random 3Gold nanoparticles help to develop a new method for tracking viruses 2Gold nanoparticles help to develop a new method for tracking viruses 3
Compact, portable device, seals 96 and 384 well plates with preset temperature optimised for Eppendorf heat sealing foils and films. Suitable for plates of different heights. AC input: 50/60 Hz230 V...
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
... Proteins (TBP). Ascites Antibody ITBP20 was raised ... acids 41-57 and may be useful in ... This antibody does not inhibit the ... nuclear extract or as a minimal activity ...
... product has been developed to significantly increase ... proteins. Stability is increased at room ... centigrade. This product is subjected to ... or azide. This formulation insures consistently ...
Biology Products: